vaccine

Light at the End of the Tunnel: Good News toward a Vaccine

photo shows an out-of-focus pink, purple, and light blue sunrise

For up there is down; for day there is night. Sunrise, sunset. You’ve heard this from us before. It’s been challenging for many of us to apply this same awareness to the global COVID-19 pandemic. Some of the earliest cases of the virus were detected this time last year, and many of us in the U.S. have been living much more restricted lifestyles since early spring of this year.

The changes we’ve made—limiting travel, exposure, contact, among others—have been a reasonable price to pay for the possibility of preserving the health and vitality of ourselves and those around us. And yet, it’s still been a long stretch. It’s had its tough moments.

But the sun keeps rising, we continue to count our blessings, and the latest scientific developments may help provide some hope.

Following a recently completed phase of a COVID-19 vaccine trial, the National Institutes of Health reported promising results, suggesting this latest “vaccine is safe and effective at preventing symptomatic COVID-19 in adults.”

This isn’t a victory by itself, but it’s certainly an important milestone in the journey forward. Many partners are working together to figure out the logistics: how a vaccine would be produced, stored, transported, distributed; how its effects would be monitored; and how other areas might be affected as the vaccine takes priority. All that is to say… it’s complex.

But it’s not impossible. And it’s not forever. It may feel like we’ve been traveling through a long, dark tunnel. Here’s the thing about tunnels: they’ve got exits. It’s possible that things are dark and that we’re still on our way.

Let’s keep our heads up, toward that glimmer of light ahead.

Clients, when you’d like to talk about what all this means for you, your plans, and your planning, reach out.


Want content like this in your inbox each week? Leave your email here.